Starting children and infants on ART; what do the guidelines say? Dr Siobhan Crowley Paediatric & Family HIV Care Department of HIV/AIDS World Heath Organization,

Slides:



Advertisements
Similar presentations
Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
Advertisements

1 TREATMENT AND PREVENTION SCALE-UP: THE SOUTH AFRICAN EXPERIENCE By Dr Moolman Team South Africa.
Key1 ARV Treatment Guidelines for a Public Health Approach Product Selection for HIV Treatment Vincent Habiyambere January 2006.
Challenges to Pediatric Antiretroviral Treatment Elaine Abrams, David Hoos MTCT-Plus.
Group Work Recommendations-When to Start Group C.
WHO Guidelines and future perspectives for treatment monitoring Nathan Ford Dept of HIV/AIDS World Health Organization.
Drug Treatment Regimens: How and why WHO makes its global recommendations Prof Charles Gilks Director, Co-ordinator Antiretroviral Treatment and Care Department.
HIV/AIDS DEPARTMENT 2013 Consolidated ARV Guidelines Treatment Recommendations for Pregnant and Breastfeeding Women: Critical Issues Dr. Nathan Shaffer.
CHER Trial: Early Antiretroviral Therapy and Mortality Among HIV- Infected Infants New England J Med 2008;359 (21):
EMTCT Tanzania Experience 6 th Joint Biennial HIV & AIDS Sector Review Dr MD Kajoka PMTCT Coordinator.
The new guidelines Dr Francois Venter Reproductive Health and HIV Research Unit University of the Witwatersrand Feb 2010.
Improving Retention, Adherence, and Psychosocial Support within PMTCT Services: Implementation Workshop for Health Workers All slide illustrations by Petra.
Dr Tin Tin Sint Department of HIV/AIDS World Health Organization
Early Infant Diagnosis: Challenges and Solutions A special session IAS, Vienna 2010.
Prescription and Use of Paediatric Antiretroviral Drugs (ARVs) for the Treatment of HIV in Children.
Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department July 20th, 2014 Evidence.
P1060 commentary Philippa Musoke MBChB Makerere University –Johns Hopkins University Research Collaboration, Kampala Uganda.
ANTIRETROVIRAL THERAPY Dr. Samuel Mwaniki (BPharm., MSc TID, UoN) University of Nairobi ISO 9001: Certified
Thailand New National Guideline for PMTCT 2010 Suchat Hongsiriwon, MD Department of Pediatrics Chonburi Hospital.
Country Experience Informing Feasibility Option B+ (Malawi) Tenofovir phase in 1 st line( Zambia) d4T phase out in HIV programmes Raising CD4 threshold.
Use of Antiretroviral Drugs for Treating Pregnant Women and
Prevention of Mother-to-Child Transmission of HIV in Ghana
Assoc.Prof. Thanyawee Puthanakit, MD. Division of Infectious Diseases, Department of Pediatric Faculty of Medicine, Chulalongkorn University AND HIVNAT,
Antiretroviral Treatment of Mothers: interrupting vertical transmission Dr Angela Mushavi National PMTCT and Pediatric HIV Care and Treatment Coordinator.
“Getting to Zero: Thailand’s Experience with E-MTCT” Petchsri Sirinirund Advisor on HIV/AIDS Policy and Programme Department of Disease Control, Thailand.
Pediatric HIV Care & Treatment in Uganda A Five-Day Training Course For Health Professionals.
Uganda National Paediatric HIV Counselling Curriculum Skills for Health Care Staff Working with Children, Adolescents and Caregivers May 2012.
ART Regimen Selection and Treatment Initiation for PMTCT Programs Lara Stabinski, MD, MPH Medical Officer Clinical Services S/GAC June 18, 2012.
WHO technical recommendations on pediatric HIV care Summary of revised recommendations on diagnosis, clinical staging & immunological classification, &
Future ART options for HIV-infected children exposed to maternal HAART Lee Kleynhans Experts Roundtable June 2008.
Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother to Child Transmission of HIV-1 in Thailand NEJM July 15, 2004 Lallemant et.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents Summary of WHO Rapid Advice December 2009 Source: WHO HIV/AIDS Department.
When to Initiate ART in Adults and Adolescents (2009 WHO Guidelines) Target PopulationClinical conditionRecommendation Asymptomatic Individuals (including.
1 Advantages and risks for a child to be exposed to the triple prophylaxis during pregnancy and breastfeeding What is the best for the child ? Pr C. Courpotin.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Crossroads Hotel 7 th January  All adolescents & adults with HIV infection & CD4 counts less than/equal to 350 cells/mm3, including pregnant women,
Human Resource Constraints and Roll out of more efficacious regimens for PMTCT The Zambian experience Nande Putta MD MPH Technical Assistant PMTCT & Paediatric.
Module II: Feeding and HIV Testing for Exposed Infants This module, we will discuss: Unit 1: Infant Feeding Guidelines Unit 2: HIV Testing and Treatment.
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
ICASA IAS Scaling up Treatment Delivery Programmes: Issues, Challenges & Best Practices Siobhan Crowley HIV Department WHO Geneva.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Update on HIV Therapy Elly T Katabira, FRCP Department of Medicine Makerere University Medical School Scaling up Treatment Programs: Issues, Challenges.
8èmes Rencontres Nord-Sud Avelin Aghokeng IRD-UMI233 & University of Montpellier I Yaoundé-Cameroon Avelin Aghokeng IRD-UMI233 & University of Montpellier.
The Pregnancy Journey Open discussion. HIV and AIDS 2013 Romania Cumulative number people diagnosed with HIV since ,261 (of which 9,946 diagnosed.
ANTEPARTUM CARE. Pregnant Women Who Are ARV Naive (1)  Pregnant women with HIV infection should receive standard clinical, immunologic, and virologic.
Dr. Philippe Chiliade Technical Advisor, Clinical Care, FHI 12 August 2008 Family Health International Lessons learned and challenges in scaling up Pediatric.
Agenda Introduction- Jessica Rodrigues, IATT Paediatric Treatment Optimization- George Silberry, Senior Technical Advisor for Pediatric HIV, OGAC Optimal.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Treatment-Experienced Patients in Resource- Limited Settings Susan M. Graham Assistant Professor, Medicine.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Estimating the Impact and Needs for Children and PMTCT Making sense: Understanding the numbers: from HIV surveillance to national and global HIV burden.
A Call to Action Children – The missing face of AIDS.
Diagram: Four stages of PMTCT Primary prevention of HIV Antenatal Care Labour and delivery Postnatal Care.
PMTCT 365 Days of Action to end the hidden violence against women and children Protecting Women early.
Scaling-up Access to Paediatric ART in India Dr. B B Rewari National AIDS Control Organisation India XVII International AIDS Conference Mexico City, 7.
WHO 2013 Consultative Meeting Tawanna Hotel October 15, 2013.
Group Work Recommendations- what to start Group WHAT 1.
The 2013 treatment guidelines and key implementation challenges Martina Penazzato IATT Normative Guidance Advisor HIV Department, WHO (Geneva, Switzerland)
Justine Mirembe MD, MPH ICASA, 5th December 2011
OVERVIEW OF PREVENTING MOTHER TO CHILD TRANSMISSION OF HIV
Early diagnosis and treatment options for children living with HIV
Providing ARVs to children in resource limited settings
What’s New in the Perinatal Guidelines
Closing the Treatment Gap of Children Living with HIV
Martina Penazzato MD, PhD Paediatric lead, HIV Department
Claire Gamble Friday 30th June 2017
Existing WHO recommendations for Paediatric ART under review
WHO Technical Reference Group Paediatric HIV/ART CARE
Gaps & obstacles Priorities & Solutions
Figure 1. Rate of PDR in infants according to ARV exposure
Presentation transcript:

Starting children and infants on ART; what do the guidelines say? Dr Siobhan Crowley Paediatric & Family HIV Care Department of HIV/AIDS World Heath Organization,

WHO recommendations Published within adult guidelines in 2003 Stand alone August 2006 Include dosing instructions (Annex E) Review meeting April ub/guidelines/art/en/ind ex.html

April 2008 –Technical Reference group meeting For infants panel reviewed: When to perform virological testing When to start ART What ARVS to start in infants with HIV WHO strongly recommends: all infants under 12 months of age with confirmed HIV infection should be started on ART, irrespective of clinical or immunological stage :

What ART to Start in infants – 2008 revision No infant or maternal ARV exposure MTCT ARV Exposure Sd NVP or NNRTI containing ART Non NNRTI exposure Unknown infant maternal MTCT Exposure NVP triple ART PI triple ART # NVP triple ART # If no PI is available use NVP triple ART Mum 34% Baby 18%

Children 1 year or over Clinical and/or immunological criteria to start ART Standard first line regimen NNRTI + 2NRTI < 3 years NVP + AZT + 3TC > 3 years EFV + AZT + 3TC Standard second line regimen PI + 2 new NRTI

Summary

Revised simplified dosing

Acknowledgments & resources: HIV Care Technical Reference group Paediatric ARV dosing working group: –Tony Nunn, Ed Caparelli, Shaffiq Essajee, Mark Mirochnick & Diana Clarke Meeting report summarising these recommendations _2008.pdf _2008.pdf Proceedings of the meeting guidelines (being updated to reflect above) Tool to assist in developing dosing recommendations A programming guide – how to scale up Paed care and treatment: Paediatric HIV care landing page